Login / Signup

Limitation and challenges in using pancreatic cancer-derived organoids as a preclinical tool.

Nicolas A FraunhofferAnalía Meilerman AbuelafiaNelson J DusettiJuan Lucio Iovanna
Published in: Cancer communications (London, England) (2022)
Keyphrases
  • cell therapy
  • stem cells
  • induced pluripotent stem cells
  • mesenchymal stem cells